1. Home
  2. AMSF vs CTKB Comparison

AMSF vs CTKB Comparison

Compare AMSF & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMERISAFE Inc.

AMSF

AMERISAFE Inc.

HOLD

Current Price

$32.50

Market Cap

630.9M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.42

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSF
CTKB
Founded
1985
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
630.9M
652.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AMSF
CTKB
Price
$32.50
$4.42
Analyst Decision
Buy
Hold
Analyst Count
3
5
Target Price
$50.33
$5.70
AVG Volume (30 Days)
165.9K
670.8K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
8.05%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$317,252,000.00
$193,015,000.00
Revenue This Year
$8.06
$5.42
Revenue Next Year
$6.34
$7.03
P/E Ratio
$13.26
N/A
Revenue Growth
2.66
17.67
52 Week Low
$32.00
$2.37
52 Week High
$53.27
$6.18

Technical Indicators

Market Signals
Indicator
AMSF
CTKB
Relative Strength Index (RSI) 32.00 50.34
Support Level $32.00 $3.81
Resistance Level $39.25 $4.60
Average True Range (ATR) 0.92 0.19
MACD -0.05 0.03
Stochastic Oscillator 0.00 67.69

Price Performance

Historical Comparison
AMSF
CTKB

About AMSF AMERISAFE Inc.

AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: